B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression

International Journal of Cancer

Volumn 126, Issue 6, 2010, Pages 1316-1326

  Leucci, Eleonora ^a   Onnis, Anna ^a   Cocco, Mario ^a   De Falco, Giulia ^a   Imperatore, Francesco ^a   Giuseppina, Antonicelli ^a   Costanzo, Valentina ^a   Cerino, Giovanna ^a   Mannucci, Susanna ^a   Cantisani, Rocco ^a   Nyagol, Joshua ^a   Mwanda, Walter ^b   Iriso, Robert ^c   Owang, Martin ^c   Schurfeld, Karin ^d   Bellan, Cristiana ^a   Lazzi, Stefano ^a   Leoncini, Lorenzo ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c St Mary's Hospital Lacor Uganda   (Uganda)

^d Department of Human Pathology ^*  (Italy)

Author keywords

Burkitt lymphoma; EBV; MicroRNAs

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; MICRORNA; X BOX BINDING PROTEIN 1;

ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; MEMORY CELL; PATHOGENESIS; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; UPREGULATION;

ADOLESCENT; ADULT; B-LYMPHOCYTES; BLOTTING, WESTERN; BURKITT LYMPHOMA; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MICRORNAS; MIDDLE AGED; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PROCESSING, POST-TRANSCRIPTIONAL; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 74949127554     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24655     Document Type: Article

References (22)

1. Swerdlow SH, Campo E, Harris NL, Jaffe E, Pileri S, Stein H, Thiele J, Vardiman J, eds. WHO classification of tumours of the haematopoietic and lymphoid tissue. Lyon: IARC, 2008; in press.
2. Bellan C, Lazzi S, Hummel M, Palummo N, de Santi M, Amato T, Nyagol J, Sabattini E, Lazure T, Pileri SA, Raphael M, Stein H, et al. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood 2005;106:1031-6.
3. Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF, Bernd HW, Cogliatti SB, Dierlamm J, Feller AC, Hansmann M-L, Haralambieva E, et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006;354:2419-30.
4. Kuo TC, Shaffer AL, Haddad J, Jr, Choi YS, Staudt LM, Calame K. Repression of BCL-6 is required for the formation of human memory B cells in vitro. J Exp Med 2007;204:819-30.
5. Shapiro-Shelef M, Lin KI, McHeyzer-Williams LJ, Liao J, McHeyzer-Williams MG, Calame K. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 2003;19:607-20.
6. Kallies A, Nutt SL. Terminal differentiation of lymphocytes depends on Blimp-1. Curr Opin Immunol 2007;19:156-62.
7. Zhao Y, Srivastava D. A developmental view of microRNA function. Trends Biochem Sci 2007;32:189-97.
8. Asirvatham AJ, Gregorie CJ, Hu Z, Magner WJ, Tomasi TB. MicroRNA targets in immune genes and the dicer/Argonaute and ARE machinery components. Mol Immunol, 2008;45:1995-2006.
9. De Falco G, Leucci E, Lenze D, Piccaluga PP, Claudio PP, Onnis A, Cerino G, Nyagol J, Mwanda W, Bellan C, Hummel M, Pileri S, et al. Gene expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt's lymphoma cell lines and primary tumors. Blood 2007;110:1301-7.
10. Thielen C, Herens C, Fassotte MF, Detrooz E, Drion P, Diss T, Boniver J, de Leval L. Establishment and characterisation of two novel human KSHV- and EBV-negative Burkitt cell lines. GAL-01 and GAL-02, from a primary lymphomatous effusion. Eur J Haematol 2006;77:318-26.
11. De Falco G, Leucci E, Onnis A, Bellan C, Tigli C, Wirths S, Cerino G, Cocco M, Crupi D, De Luca A, Lanzavecchia A, Tosi P, et al. Cdk9/Cyclin T1 complex a key player during the activation/differentiation process of normal lymphoid B cells. J Cell Physiol 2008;215:276-82.
12. Fearon DT, Manders PM, Wagner SD. Bcl-6 uncouples B lymphocyte proliferation from differentiation. Adv Exp Med Biol 2002;512:21-8.
13. McHeyzer-Williams LJ, McHeyzer-Williams MG. Antigen-specific memory B cell development. Annu Rev Immunol 2005;23:487-513.
14. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006;6:259-69.
15. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004;101:2999-3004.
16. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-8.
17. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006;103:2257-61.
18. Leucci E, Cocco M, Onnis A, De Falco G, van Cleef P, Bellan C, van Rijk A, Nyagol J, Byakika B, Lazzi S, Tosi P, van Krieken H, et al. Altered expression of c-myc-regulating miRNAs in MYC negative endemic Burkitt lymphoma cases. J Pathol 2008;216:440-50.
19. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, Jones PA. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin modifying drugs in human cancer cells. Cancer Cell 2006;9:435-43.
20. Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi JT, Braich R, Manoharan M, Soutschek J, Ohler U, Cullen BR. A viral microRNA functions as an orthologue of cellular miR-155. Nature 2007;450:1096-9.
21. Saito M, Gao J, Basso K, Kitagawa Y, Smith PM, Bhagat G, Pernis A, Pasqualucci L, Dalla Favera R. A signaling pathway mediating down-regulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell 2007;12:280-92.
22. Cattoretti G, Shaknovich R, Smith PM, Jäck HM, Murty VV, Alobeid B. Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance. J Immunol 2006;177:6930-9.